Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica flag Jamaica · Delayed Price · Currency is JMD
2.640
0.00 (0.00%)
At close: Sep 28, 2026

Indies Pharma Jamaica Cash Flow Statement

Millions JMD. Fiscal year is Nov - Oct.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Net Income
133.31181.29221.18213.06220.79167.87
Depreciation & Amortization
66.7365.8761.4460.1656.8453.73
Loss (Gain) From Sale of Assets
----3.07-1.88-2.4
Other Operating Activities
93.179.0592.7469.759.0762.95
Change in Accounts Receivable
-135.81-15.398.59-103.5-5.3260.12
Change in Inventory
22.7592.46-78.195.1347.09-76.08
Change in Accounts Payable
47.1121.9-26.0129.263.03-31.49
Change in Income Taxes
-11.76-44.18-22.167.87--0.14
Change in Other Net Operating Assets
165.85-117.19-7.570.88-64.39131.91
Operating Cash Flow
381.26363.81250.01279.47315.22366.48
Operating Cash Flow Growth
-5.24%45.52%-10.54%-11.34%-13.99%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Capital Expenditures
-47.89-43.52-8.88-14.02-26.37-40.72
Sale of Property, Plant & Equipment
---3.531.882.98
Sale (Purchase) of Intangibles
-31.98-32.98-19.98-62.44-61.68-202.93
Investment in Securities
---63.1467.310.75
Other Investing Activities
1.861.121.621.460.954.84
Investing Cash Flow
-78-75.38-27.24-8.33-17.92-235.09

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Short-Term Debt Issued
-1.45-0.06--
Long-Term Debt Issued
-1,000--3.430.6
Total Debt Issued
992.231,001-0.063.430.6
Short-Term Debt Repaid
---0.29---
Long-Term Debt Repaid
--848.31-41.76-46.35-48.16-46.63
Lease Payments
-31.29-43.31-41.76-46.35-48.16-46.63
Total Debt Repaid
-836.29-848.31-42.05-46.35-48.16-46.63
Net Debt Issued (Repaid)
155.94153.14-42.05-46.29-44.73-46.03
Common Dividends Paid
-179.89-179.89-146.58-150.98-150.58-146.58
Other Financing Activities
-88.65-61.95-63.8-56.35-56.2-61.37
Financing Cash Flow
-112.6-88.71-252.42-253.62-251.5-253.99

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Foreign Exchange Rate Adjustments
---0.450.1-
Net Cash Flow
202.82199.73-29.6517.9845.89-122.59

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Free Cash Flow
333.38320.3241.13265.45288.85325.76
Free Cash Flow Growth
-6.57%32.83%-9.16%-8.10%-11.33%-
Free Cash Flow Margin
29.57%28.44%20.80%25.15%30.82%38.47%
Free Cash Flow Per Share
0.250.240.180.200.220.24
Levered Free Cash Flow
77.89241.9848.6873.53111.44-74.56
Unlevered Free Cash Flow
133.75281.1788.97115.27149.24-31.46
Free Cash Flow After Leases
302.09276.98199.37219.1240.68279.13

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Cash Interest Paid
92.6561.9563.856.3556.261.37
Cash Income Tax Paid
----0.32-
Change in Working Capital
88.1337.6-125.34-60.38-19.684.32